Post by
sicnarf2 on Oct 16, 2015 2:04pm
Bob McQuarter just on BNN
Said there is too much competition in this space and they are all trying to do the same thing.Grow by acquisition.
Comment by
lscfa on Oct 16, 2015 2:32pm
Saw that. McWhirter is not informed. He was also asked about CRH and talked about the legacy o ring product without even a mention of the gastro business.
Comment by
peter75 on Oct 16, 2015 2:46pm
On market call on bnn he made Nhc his top pick at 9.15 dont trust these clowns they buy now when there telling you to stay away they sell when they tell you to buy
Comment by
peter75 on Oct 16, 2015 2:47pm
See stockchase for this on Nhc, may 2015
Comment by
lscfa on Oct 16, 2015 2:59pm
He also suggested MSL was pricy with eps estimated at $0.06 next year. But the cash eps are over $0.20. He can not be that stupid. I suspect he is downplaying it so he can take a position.....
Comment by
lscfa on Oct 16, 2015 4:20pm
Piss off basher. McWhirter is a quant guy. He relies of eps estimates of analysts. Analysts may be estimating $0.06 for next year but they do not rely on that number to value the company. They use ebitda as a proxy for cash flows because MSL has huge non-cash expenses like amort or intangibles. Fund managers like Donville use cash eps to value these company. Accounting eps is a bogus number.
Comment by
Craigbad on Oct 17, 2015 12:41pm
Get freaking real. 2016 eps estimate $0.69 X 15 p/e multiple = $10.35.... Read more at https://www.stockhouse.com/companies/bullboard/bullboard/t.nhc/nobilis-health-corp#8r2dbACH80UdqmSV.99 using the multiple you yourself used on the nhc board for a target it would work out like this iscfa 15 x .06 eps estimate = $0.90 price per share in your own words, get freakin real
Comment by
lscfa on Oct 17, 2015 1:18pm
This post has been removed in accordance with Community Policy
Comment by
peter75 on Dec 24, 2015 9:46am
Reading this his post makes me laugh, readers ignore the jerks on this board and follow the best tool of them all commonsence